MARKET

BMRN

BMRN

Biomarin Pharmaceutical Inc
NASDAQ
58.86
+1.51
+2.63%
Opening 10:07 06/26 EDT
OPEN
57.35
PREV CLOSE
57.35
HIGH
59.08
LOW
57.35
VOLUME
276.03K
TURNOVER
--
52 WEEK HIGH
66.28
52 WEEK LOW
49.26
MARKET CAP
11.38B
P/E (TTM)
42.95
1D
5D
1M
3M
1Y
5Y
1D
Bio-Techne Corp. Stock Rises 20.1%, Outperforms Peers
Dow Jones · 17h ago
Did New VOXZOGO and BMN 333 Data Just Shift BioMarin Pharmaceutical's (BMRN) Investment Narrative?
Simply Wall St · 3d ago
Incyte Corp. Stock Rises 5.5%, Outperforms Peers
Dow Jones · 3d ago
Spruce Biosciences names Agnieszka Jurecka vice president, medical affairs
PUBT · 4d ago
H.C. Wainwright Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)
TipRanks · 4d ago
Weekly Report: what happened at BMRN last week (0615-0619)?
Weekly Report · 4d ago
3 US Pharmaceutical Stocks With Cash Flow And Pricing Risk
Simply Wall St · 6d ago
Bio-Techne Corp. Stock Rallies 5.3%, Outperforms Peers
Dow Jones · 06/18 20:35
More
About BMRN
BioMarin Pharmaceutical Inc. is a global biotechnology company engaged in the development of genetic discovery into medicines that make an impact on the life of each patient. The Company has a portfolio of commercial therapies and a clinical and preclinical pipeline. Its commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno-associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Its Galafold (migalastat) is the first oral treatment for Fabry disease, and Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat), is a two-component therapy for Pompe disease.

Webull offers Biomarin Pharmaceutical Inc stock information, including NASDAQ: BMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMRN stock methods without spending real money on the virtual paper trading platform.